Clay Thorp - 10 Jun 2021 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Brian F. Leaf, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 17:33:26 UTC
Previous filing
04 Jun 2021
Next filing
18 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 10 Jun 2021 Common Stock 25,000 $3.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 10, 2022.